Podcasts about patient centered

The George Washington Cancer Center serves a racially, ethnically, and socioeconomically diverse population across Washington, D.C., northern Virginia, and southern Maryland. Their Breast Cancer Program has found that a community-informed model is most successful for managing care and adverse events related to CDK4/6 inhibitors. In this episode, CANCER BUZZ speaks with Pavani Chalasani, MD, MPH, director of the division of hematology/oncology at the George Washington University Cancer Center about the flexible and collaborative team design that allows for culturally responsive and comprehensive care for their patients with breast cancer.   Pavani Chalasani, MD, MPH  Director, Division of Hematology/Oncology George Washington University Cancer Center Washington, DC   “I think adapting and knowing what the barriers are and how we can divide and support and come up with roles for our team members is essential.” “[Navigators] give us an understanding of where the hesitancy is coming from, or where the concerns are coming from, so that we can do a better job explaining and overcoming those barriers.”   Resources ·      Spotlight on George Washington (GW) Cancer Center: Managing Adverse Effects of CDK4/6 Inhibitors With a Patient-Centered, Team-Based Approach ·      ACCC Resource: CDK4/6 Inhibitors Management ·      ACCC CDK4/6 Inhibitors Infographic

Please visit answersincme.com/860/MED-ONC-03349-replay to participate, download slides and supporting materials, complete the post test, and obtain credit. In this activity, experts discuss how the latest data for first-line immunotherapy-based regimens informs personalized approaches for advanced NSCLC and how to elevate care through patient advocate–centered approaches. Upon completion of this activity, participants should be better able to: Differentiate the clinical profiles of NCCN-preferred first-line immunotherapy-based regimens for advanced NSCLC based on the latest data for disease with no actionable mutations and PD-L1 expression 50% or greater; Identify how first-line treatment selection varies for different patient subpopulations with advanced NSCLC with no actionable mutations and PD-L1 expression 50% or greater; and Apply patient-centered strategies to optimize the integration of immunotherapy-based regimens into first-line treatment plans of patients with advanced NSCLC with no actionable mutations and PD-L1 expression 50% or greater.

What does it take to lead successful drug development—whether at a global pharma giant or a small biotech start-up?In this episode of SNiPs, Dr. David Krause joins Bracken CEO Dr. Colin Miller to reflect on three decades of experience spanning large organizations like GSK to fast-moving start-ups. From aligning clinical development with medical affairs to serving “many masters” in drug development, patients, regulators, providers, and marketers, Dr. Krause shares insights on how to keep the patient at the center while driving innovation forward.Topics include:Lessons learned moving from big pharma to start-upsThe evolving relationship between medical affairs and clinical developmentBalancing regulatory, commercial, and patient prioritiesWhy knowing what you don't know is key to success in smaller companiesListen to this episode of Fractals: Life Science Conversations wherever you get your podcasts—and connect with Bracken to learn how we support drug development from concept to approval.

In this episode of What's Up Public Health, we sit down with Ingrid, a Speech Language Pathologist, to explore the profound impact of shifting diversity, equity, and inclusion (DEI) language within the field of speech-language pathology. With recent language changes from the American Speech-Language-Hearing Association (ASHA) to the accreditation, professionals are grappling with how these shifts influence not only their work but also the communities they serve.Together, we unpack how words shape practice, professional identity, and patient trust—and what's at stake when DEI language is removed from the conversation. From the clinician's role as an advocate to the ripple effects on patient care, this episode dives deep into the power of language in advancing health equity.

In this episode, Rick shares his interview with Dr. Neli Augustson, physician, healer, and founder of a direct primary care practice that puts patients before systems. She shares her inspiring journey from growing up in Gabon to experiencing compassionate care in the U.S. for the first time, which fueled her passion for medicine.Neli opens up about leaving the traditional healthcare system to create a practice built on prevention, accessibility, and personalized attention—where every patient is seen, heard, and cared for without insurance interference. She explains how kindness, listening, and trust can transform healthcare, and why taking a leap of faith was the only way to serve her patients the way she believed they deserved.Her story is a powerful reminder that true change often begins with doing what's right, even when it's hard.This episode is a MUST-LISTEN!

Evaluation of a Novel Patient-Centered Methadone Restart Protocol 

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/PXM865. CME/MOC/AAPA credit will be available until August 26, 2026.From Migraine Recognition to Relief: Improving Outcomes With Patient-Centered CGRP Antagonist Strategies In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Pfizer.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/PXM865. CME/MOC/AAPA credit will be available until August 26, 2026.From Migraine Recognition to Relief: Improving Outcomes With Patient-Centered CGRP Antagonist Strategies In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Pfizer.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/PXM865. CME/MOC/AAPA credit will be available until August 26, 2026.From Migraine Recognition to Relief: Improving Outcomes With Patient-Centered CGRP Antagonist Strategies In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Pfizer.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/PXM865. CME/MOC/AAPA credit will be available until August 26, 2026.From Migraine Recognition to Relief: Improving Outcomes With Patient-Centered CGRP Antagonist Strategies In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Pfizer.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/PXM865. CME/MOC/AAPA credit will be available until August 26, 2026.From Migraine Recognition to Relief: Improving Outcomes With Patient-Centered CGRP Antagonist Strategies In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Pfizer.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/PXM865. CME/MOC/AAPA credit will be available until August 26, 2026.From Migraine Recognition to Relief: Improving Outcomes With Patient-Centered CGRP Antagonist Strategies In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Pfizer.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/PXM865. CME/MOC/AAPA credit will be available until August 26, 2026.From Migraine Recognition to Relief: Improving Outcomes With Patient-Centered CGRP Antagonist Strategies In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Pfizer.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/PXM865. CME/MOC/AAPA credit will be available until August 26, 2026.From Migraine Recognition to Relief: Improving Outcomes With Patient-Centered CGRP Antagonist Strategies In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Pfizer.Disclosure information is available at the beginning of the video presentation.

In this episode of Mission Matters, host Adam Torres interviews Delbert Arrendale, Founder and CEO of Interoperable Systems and Images (ISI). Delbert shares his mission to make healthcare more affordable and effective by solving one of the industry's biggest challenges: inaccessible and siloed clinical data. With AI-powered solutions and a focus on underserved rural communities, ISI is putting patients at the center of their care while reducing costs from duplicate testing and inefficient systems. Follow Adam on Instagram at https://www.instagram.com/askadamtorres/ for up to date information on book releases and tour schedule. Apply to be a guest on our podcast: https://missionmatters.lpages.co/podcastguest/ Visit our website: https://missionmatters.com/ More FREE content from Mission Matters here: https://linktr.ee/missionmattersmedia Learn more about your ad choices. Visit podcastchoices.com/adchoices

In this episode of Mission Matters, host Adam Torres interviews Delbert Arrendale, Founder and CEO of Interoperable Systems and Images (ISI). Delbert shares his mission to make healthcare more affordable and effective by solving one of the industry's biggest challenges: inaccessible and siloed clinical data. With AI-powered solutions and a focus on underserved rural communities, ISI is putting patients at the center of their care while reducing costs from duplicate testing and inefficient systems. Follow Adam on Instagram at https://www.instagram.com/askadamtorres/ for up to date information on book releases and tour schedule. Apply to be a guest on our podcast: https://missionmatters.lpages.co/podcastguest/ Visit our website: https://missionmatters.com/ More FREE content from Mission Matters here: https://linktr.ee/missionmattersmedia Learn more about your ad choices. Visit podcastchoices.com/adchoices

How can healthcare investment banking put patients—not just profits—at the center of biotech deals? In this episode, host James Zanewicz, JD, LLM, RTTP, speaks with Sam Libby, President and Managing Director of TCB Capital Advisors. Drawing from more than $20 billion in transactions across therapeutics, diagnostics, and digital health, Sam explains how TCB's unique advisory model partners with companies before and after deals close. From growing up with therapist parents to founding a merchant bank, Sam shares how personal values and professional experience can come together to shape smarter strategies for healthcare innovation. In this episode, you'll learn: Why patient-centered thinking belongs at the core of investment strategy. Common mistakes healthcare startups make when pitching to investors—and how to avoid them. The critical role of clinical data, mission alignment, and timing in building sustainable biotech companies. Tune in to learn how to navigate healthcare investments with purpose and ensure your biotech mission makes a lasting impact. Links: Connect with Sam Libby, and check out TCB Capital Advisors. Connect with James Zanewicz, JD, LLM, RTTP and learn about Tulane Medicine Business Development and the School of Medicine. Learn more about Clairity and Informuta. Listen to our previous episode on Drug Pricing and Accessibility. Connect with Ian McLachlan, BIO from the BAYOU producer. Check out BIO on the BAYOU and make plans to attend October 28 & 29, 2025. Learn more about BIO from the BAYOU - the podcast. Bio from the Bayou is a podcast that explores biotech innovation, business development, and healthcare outcomes in New Orleans & The Gulf South, connecting biotech companies, investors, and key opinion leaders to advance medicine, technology, and startup opportunities in the region.

It's the 11th running of the Race For the Future in Fort Worth, TX on September 14, 2025. This is YOUR chance to make a difference in a industry we all love so much. Important links: All the money goes to The Foundation For Dental Laboratory Technology: https://dentallabfoundation.org/ All about the Race: https://dentallabfoundation.org/news-events/race-for-the-future/ Race website: https://fortworth.californiatriathlon.org/ TO DONATE: https://fdlt.memberclicks.net/donor-form#/ Select: Race for the Future Enter the name of the racer you want to support: BARB WARNER or THE CROWN JEWELS Enter the amount (One Million Dollars) A HUGE thanks to Jensen Dental (https://jensendental.com/) for allowing Elvis to go to one of the greatest regional shows left, the https://www.fdla.net/ Southern States Symposium & Expo. First up we meet two "newish" technicians in our industry. From Alaska to Florida, Savannah Jones taught herself exocad and is now doing removable work at DCS Dental Lab (https://dcslab.com/). Gabriel Jimenez was working at Walmart when he found a dental office that had an in-office lab and it wasn't long before he too found himself at DCS Dental Lab. They talk about their journey, learning new things, and what they think of their first dental show. Then a blast from WAY back comes on to update us on all things Tom Zaleske. Tom was on episode 16 (if you can believe it)! He talks about his journey to become a one person removable technician working out of his house, getting into speaking and what he speaks on, and some thoughts on the future of dental labs. Then we wrap up the episode with another past podcast guest, Josh Williams. Josh is at GPS Digital RPD (https://gpsdigitalrpd.com/) where they are killing it at printing metal frameworks. He talks about their growth, the process of fabrication, and how easy it is to get them a case. Looking for a way to unlock the full potential of your digital dentistry workflow. Take it from Elise Heathcote, associate manager of digital services with Ivoclar. This is all about the Cam Academy. They have a new in-person training experience designed specifically for dental technicians. This hands on course explores the full potential of programmable Cam software, helping you take your digital workflow to the next level. Learn directly from Ivoclar experts, refine your skills and bring new precision and efficiency to your lab. Cam Academy is more than a course. It's your next step in digital excellence. To reserve your spot, visit the Ivoclar Academy website (https://www.ivoclar.com/en_us/academy/learning-opportunities?page=1&offset=12&filters=%5B%7B%22id%22%3A%22dateRange%22%2C%22selectedLowerBound%22%3A%222021-12-09T07%3A30%3A45.534Z%22%2C%22selectedUpperBound%22%3A%222022-06-09T06%3A30%3A45.534Z%22%7D%2C%7B%22id%22%3A%22type%22%2C%22advancedFilter%22%3Afalse%2C%22values%22%3A%5B%22In-house+trainings%22%5D%7D%5D) or contact your local Ivoclar sales representative today. Special Guests: Gabriel Jimenez, Josh Williams, Savannah Jones, and Thomas Zaleske, AS.

1005: "Great innovations are painkillers, not vitamins." In this episode, Peter High speaks with Shez Partovi, Chief Innovation & Strategy Officer and Chief Business Leader of Enterprise Informatics at Royal Philips, a €18B global health technology leader. Shez shares how Philips is building people- and patient-centric innovation by partnering with healthcare providers, co-creating solutions, and scaling software and AI-driven insights to meet the growing demands of modern care delivery. A former AWS health exec and practicing neuroradiologist, Shez offers a unique lens on the convergence of tech and clinical practice. He outlines how Philips' software-first strategy is accelerating productivity, reducing clinician burnout, and expanding access to care while also navigating AI trust gaps and reshaping internal engineering practices. Key themes include: The strategy behind Philips' health tech transformation AI's role in automation, augmentation, and agility in care delivery Co-creation with health systems to drive scalable impact Philips' dual-speed innovation model (80% business-led, 20% moonshots)

Dr. Pat Harty, Interventional Radiologist at MIC Imaging and Procedure Center, where he helps patients access minimally invasive procedures in a calm, patient-first setting joins … Read more The post Precision Without Pressure: What Every Industry Can Learn from Patient-Centered Healthcare appeared first on Top Entrepreneurs Podcast | Enterprise Podcast Network.

On this episode, we provide an overview of insulin. We discuss the various insulin products available, basal vs prandial insulin, and dosing strategies. We also review clinical concepts such as overbasalization.  Cole and I are happy to share that our listeners can claim ACPE-accredited continuing education for listening to this podcast episode! We have continued to partner with freeCE.com to provide listeners with the opportunity to claim 1-hour of continuing education credit for select episodes. For existing Unlimited (Gold) freeCE members, this CE option is included in your membership benefits at no additional cost! A password, which will be given at some point during this episode, is required to access the post-activity test. To earn credit for this episode, visit the following link below to go to freeCE's website: https://www.freece.com/ If you're not currently a freeCE member, we definitely suggest you explore all the benefits of their Unlimited Membership on their website and earn CE for listening to this podcast. Thanks for listening! If you want to support the podcast, check out our Patreon account. Subscribers will have access to all previous and new pharmacotherapy lectures as well as downloadable PowerPoint slides for each lecture. If you purchase an annual membership, you'll also get a free digital copy of High-Powered Medicine 3rd edition by Dr. Alex Poppen, PharmD. HPM is a book/website database of summaries for over 150 landmark clinical trials.You can visit our Patreon page at the website below:  www.patreon.com/corconsultrx We want to give a big thanks to Dr. Alex Poppen, PharmD and High-Powered Medicine for sponsoring the podcast..  You can get a copy of HPM at the links below:  Purchase a subscription or PDF copy - https://highpoweredmedicine.com/ Purchase the paperback and hardcover - Barnes and Noble website We want to say thank you to our sponsor, Pyrls. Try out their drug information app today. Visit the website below for a free trial: www.pyrls.com/corconsultrx We also want to thank our sponsor Freed AI. Freed is an AI scribe that listens, prepares your SOAP notes, and writes patient instructions. Charting is done before your patient walks out of the room. You can try 10 notes for free and after that it only costs $99/month. Visit the website below for more information: https://www.getfreed.ai/  If you have any questions for Cole or me, reach out to us via e-mail: Mike - mcorvino@corconsultrx.com Cole - cswanson@corconsultrx.com

My guest today is pathologist Dr Jeff Myers. What we discuss with DR Myers: Dr. Myers' path to pathology His career at Mayo Clinic The transition to University of Michigan The beginning of patient-centered pathology Creating the Patient and Family Advisory Council Challenges and innovations in Pathology Clinics Stories of interacting with patients and their families Reinventing lab design The role of collaboration in pathology Reviving a passion for music Reflecting on a career in pathology Links for this episode: The Path to PathA Pathologists' Assistant Shadowing Network Health Podcast Network  LabVine Learning Dress A Med scrubs Digital Pathology Club   Honoring Dr. Jeffrey Myers: A Trailblazer in Pathology Moves to Retirement Institute for Patient and Family-Centered Care Bringing Patients and Pathology Together: An Interview with Jeffrey Myers, MD Peer-to-Peer, Featuring Jeffrey Myers: How to build a rewarding career by following instincts and aiming to do the right thing   People of Pathology Podcast: Twitter Instagram  

Please visit answersincme.com/ZXA860 to participate, download slides and supporting materials, complete the post test, and obtain credit. In this activity, experts in interstitial lung disease (ILD) discuss the latest information, including post-congress insights, on advancing patient-centered ILD care with antifibrotics, treatment innovations, and multidisciplinary approaches. Upon completion of this activity, participants should be better able to: Assess recommended antifibrotic treatment for patients with ILDs; Review the rationale for novel therapy for fibrosing ILDs; and Outline multidisciplinary, patient-centered strategies to enhance care for individuals with ILDs.

Please visit answersincme.com/ZXA860 to participate, download slides and supporting materials, complete the post test, and obtain credit. In this activity, experts in interstitial lung disease (ILD) discuss the latest information, including post-congress insights, on advancing patient-centered ILD care with antifibrotics, treatment innovations, and multidisciplinary approaches. Upon completion of this activity, participants should be better able to: Assess recommended antifibrotic treatment for patients with ILDs; Review the rationale for novel therapy for fibrosing ILDs; and Outline multidisciplinary, patient-centered strategies to enhance care for individuals with ILDs.

Today my guest is patient advocate Michele Mitchell. What we discuss with Michele: Her personal cancer battle The treatment journey Seeing the enemy - a pivotal moment Pathology Clinics and patient experience Expanding advocacy to national level The 21st Century Cures Act and what it means for patients MyPathologyReport.ca - A Patient's Perspective AI in patient-centered pathology Speaking Engagements and Advocacy Advice for patients and families Links for this episode: The Path to PathA Pathologists' Assistant Shadowing Network Health Podcast Network  LabVine Learning Dress A Med scrubs Digital Pathology Club   Clinicians Are From Mars and Pathologists Are From Venus: Clinician Interpretation of Pathology Reports ASCP Patient Champions Program Digital Pathology Association Patient Engagement Committee University of Michigan Patient and Family Advisory Council My Pathology Report   People of Pathology Podcast: Twitter Instagram  

CME credits: 1.00 Valid until: 15-07-2026 Claim your CME credit at https://reachmd.com/programs/cme/the-latest-patient-centered-recommendations-from-the-7th-world-symposium-on-ph/33236/ Managing patients with pulmonary arterial hypertension, or PAH, can present certain challenges. PAH is a serious, progressive condition, and its effective management involves the consideration of several factors to meet treatment goals. The utilization of patient-reported outcome measures (PROMs) to enhance shared decision-making can be a valuable tool to help integrate lifestyle, palliative care, and patient goals into a PAH care plan and address diverse and global needs.

In this episode of To Care Is Human, Terri Ipsen talks with Susan Osborne about the power of words in healthcare. Based on her PX blog, “Say this instead of,” Susan shares practical tips and real examples of how small language changes can ease anxiety, build trust, and improve patient experience. Learn how intentional communication can make a lasting difference in patient care across all healthcare settings. 

Dr. Tharwat Ghattas, an oncologist with Highland Clinic in Shreveport and Monroe, shares how he approaches one of the most pivotal moments in a patient's life: hearing the words "you have cancer." In this episode, Dr. Ghattas discusses the power of the first conversation after diagnosis, the importance of listening to a patient's fears and emotions, and how collaborative goal-setting lays the foundation for compassionate, personalized care. By centering the patient's voice from day one, he helps transform fear into clarity—and a plan for moving forward.

Synopsis: When an introverted engineer becomes the President & CEO of REGENXBIO, transformation follows. Curran Simpson joins host Rahul Chaturvedi to unpack his unlikely journey from biotech operations to the C-suite—and how that hands-on experience is reshaping gene therapy's future. They dive into the evolution of REGENXBIO's pipeline, tackling ultra-rare diseases like MPS II, ambitious plans for Duchenne Muscular Dystrophy, and commercial partnerships with giants like AbbVie. Curran offers hard-earned leadership lessons, honest reflections on scaling science, and insights into how one-time gene therapies could revolutionize treatment in both rare and common diseases. From clinical nuance to strategic boldness, this is a masterclass in biotech leadership, platform focus, and staying patient-first—no matter how complex the science or market. Biography: Curran M. Simpson is the President and Chief Executive Officer and member of the Board of Directors at REGENXBIO. Mr. Simpson previously served as the Company's Chief Operating Officer. In that role, he led key business functions including Research & Clinical Development, Corporate Strategy, Manufacturing & Quality, Regulatory, and Commercial Operations. Mr. Simpson joined REGENXBIO in 2015 with extensive leadership experience across biopharmaceutical operations and served as the Company's Chief Technology and Operations Officer before becoming COO. Prior to joining REGENXBIO, he was the Regional Supply Chain Head for North America and Interim Chief Operating Officer at GlaxoSmithKline (GSK). Mr. Simpson earlier served as interim CEO of Human Genome Sciences (HGS), where he led the integration of HGS into GSK, and as Senior Vice President of Operations and Vice President of Manufacturing Operations at HGS. Prior to HGS, Mr. Simpson was Director of Manufacturing Sciences at Biogen. Earlier in his career, Mr. Simpson served in an overseas assignment at Novo-Nordisk Biochem in Denmark and in various senior development and engineer roles at Genentech, working on Herceptin and Avastin, among other roles. Mr. Simpson has an M.S. in surface and colloid science from Clarkson University and a B.S. in chemistry from the Clarkson College of Technology.

Do you know why programmed death-ligand 1 (PD-L1) testing and targeted therapy are so important for improving patient care? Credit available for this activity expires: 6/27/26 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1002597?ecd=bdc_podcast_libsyn_mscpedu

Please visit answersincme.com/ABT860 to participate, download slides and supporting materials, complete the post test, and obtain credit. In this activity, an expert in neurology discusses the clinical evidence for novel complement (C5) inhibitors in the treatment of generalized myasthenia gravis (gMG) and personalized multidisciplinary management strategies. Upon completion of this activity, participants should be better able to: Review the rationale for novel C5 inhibitors in the treatment of generalized myasthenia gravis (gMG); Describe the long-term clinical data of C5 inhibitors for the treatment of gMG; and Discuss strategies to personalize multidisciplinary management plans for patients with gMG.

Please visit answersincme.com/ABT860 to participate, download slides and supporting materials, complete the post test, and obtain credit. In this activity, an expert in neurology discusses the clinical evidence for novel complement (C5) inhibitors in the treatment of generalized myasthenia gravis (gMG) and personalized multidisciplinary management strategies. Upon completion of this activity, participants should be better able to: Review the rationale for novel C5 inhibitors in the treatment of generalized myasthenia gravis (gMG); Describe the long-term clinical data of C5 inhibitors for the treatment of gMG; and Discuss strategies to personalize multidisciplinary management plans for patients with gMG.

The Shared Decision-Making-Renal Supportive Care intervention elicited dialysis patient preferences for end-of-life care. The HIGHWay project updated this intervention to scale it for broader implementation of advance care planning.

Counseling patients with intermediate-risk non-muscle invasive bladder cancer can be complex, with a wide range of treatment options and care pathways. In this episode of BackTable Urology, urologic oncologists Dr. Ruchika Talwar and Dr. Kelly Bree explore how to approach this challenge with clarity and compassion. --- This podcast is supported by an educational grant from UroGen Pharma. --- SYNPOSIS They emphasize a shift toward patient-centered, less aggressive treatment strategies, highlighting the importance of quality of life in clinical decision-making. The discussion includes risk stratification, the use of intravesical gemcitabine, and ongoing clinical trials. Dr. Bree also offers actionable tips for optimizing patient preparation and recovery. This episode underscores the growing importance of listening to patient voices to shape future standards of care. --- TIMESTAMPS 00:00 - Introduction and Overview02:09 - Risk Stratification and Treatment Approaches06:12 - Intravesical Therapy Options08:47 - Quality of Life and Patient Counseling12:56 - Practical Tips for TURBT Recovery17:03 - In-Office Procedures and Patient Management21:23 - Resources and Support for Patients24:13 - Future Directions and Final Thoughts --- RESOURCES Society of Urologic Oncologyhttps://suonet.org/home.aspx

Jason Wolf, President and CEO of The Beryl Institute, speaks with Jennifer Bright, MPA, President of the International Consortium for Health Outcomes Measurement (ICHOM). In this insightful conversation, Jennifer shares her personal journey and passion for transforming healthcare. Together, they explore the vital role of patient centricity and why embracing a global perspective is essential to advancing healthcare experiences worldwide.

Listen in as Joseph Kim, MD, MPH, MBA, interviews Natalie, Orbach, PA-C, to learn about how she implemented patient-centered and individualized treatment plans to improve obesity care at her practice, includingDiscussing weight and how nutrition, physical activity, mental health, and pharmacotherapy strategies can helpMeeting patients where they are at and offering slow, incremental changes that support long-term outcomesReferring patients to community resources and other professionals as needSharing lessons learned for those interested in implementing similar strategies in their practice PresenterJoseph Kim, MD, MPH, MBAPresidentQ Synthesis, LLCNewtown, PennsylvaniaNatalie Orbach, PA-CPhysician AssistantFeirtag & Ramos, PALutherville, Maryland Link to full program: https://bit.ly/45P0v8z

In this episode, Drs. Vivian Bishay, Wissam Jaber and Dr. Vlad Lakhter review safety, patient selection, and risk stratification related to device selection. They examine the economics of outcomes in PE treatment, including workflow efficiency and the impact of avoiding post-procedure infusion and ICU resource use. Discussion ensues on the role of treatment location, ease of use, and how broader access to technology may influence care delivery.

CME credits: 0.25 Valid until: 02-06-2026 Claim your CME credit at https://reachmd.com/programs/cme/fsgs-in-practice-patient-centered-decision-making/35713/ Focal segmental glomerulosclerosis (FSGS) is a prominent cause of kidney failure globally, necessitating dialysis for patient survival as the disease progresses. However, the current absence of FDA-approved treatments tailored specifically for treating adult and pediatric patients with FSGS poses a significant challenge to effectively managing this disease. Moreover, it is imperative for nephrologists to enhance their skills to implement practical strategies that improve the diagnostic approach for suspected FSGS cases, especially considering the profound impact of FSGS on patients' quality of life. This activity has been designed to provide practical guidance for the accurate diagnosis of FSGS and appropriate treatment selection, as well as to offer an expert assessment of the clinical trial data supporting emerging therapies in this setting. =

Send us a textMy guest this week is Yasmin Sharifi, an operating room nurse with many decades of experience. She's here to give us a glimpse into, as she says, “what really goes on behind that red line.”Yasmin didn't initially set out to be an OR nurse. She started her career in med-surg but quickly encountered burnout due to a nursing shortage and inadequate patient-to-nurse ratios, often sharing 35 patients with another nurse. Realizing this was not sustainable, she transitioned to the PACU. When she was offered a chance to move into the operating room, she embraced the opportunity and discovered her true passion.Yasmin pointed out that in 1990, there were no formal orientation programs for OR nurses. However, resourcefulness is a nurse's superpower. She joined the professional organization AORN, purchased relevant books, and trained herself to adapt to the role.Fortunately, those days are behind us. Nurses entering the operating room today receive a comprehensive education and an orientation period that lasts nearly a year. And if you think being an OR nurse means you won't have to interact with patients and their families, Yasmin dispels that myth completely.We discussed the dynamics among the operating room team members, the egos involved, and the common goal that brings them all together: the patient. I'm confident you'll enjoy and learn from our discussion.After being in charge for almost her entire career, Yasmin has now taken charge of her own business, OR RN Mentor. Here, she provides expert insights, practical tips, and real-world experiences designed to help others thrive in the OR. Now that's what I call giving back.In the five-minute snippet: it's 80's rock for the win. For Yasmin's bio, visit my website (link below) and check out my CE library to see if you can earn CE's just for listening!CNOR Certified Perioperative NurseAORN Association of Perioperative Registered NursesIFPN International Federation of Perioperative NursesContact The Conversing Nurse podcastInstagram: https://www.instagram.com/theconversingnursepodcast/Website: https://theconversingnursepodcast.comYour review is so important to this Indie podcaster! You can leave one here! https://theconversingnursepodcast.com/leave-me-a-reviewWould you like to be a guest on my podcast? Pitch me! https://theconversingnursepodcast.com/intake-formCheck out my guests' book recommendations! https://bookshop.org/shop/theconversingnursepodcast I've partnered with RNegade.pro! You can earn CE's just by listening to my podcast episodes! Check out my CE library here: https://rnegade.thinkific.com/collections/conversing-nurse-podcast Thanks for listening!

This episode recorded live at the Becker's Hospital Review 15th Annual Meeting features David Carmouche, MD, Executive Vice President & Chief Clinical Transformation Officer at Lumeris. Dr. Carmouche discusses how Lumeris is leveraging AI to redefine primary care delivery, scale access, and improve outcomes—without sacrificing quality or provider trust.This episode is sponsored by Lumeris.

How do you turn vaccine hesitancy into a clinical and business success?     Abe Funk, PharmD, shares how a CPESN®-provided grant enabled pharmacies in Missouri to expand vaccination efforts beyond the pharmacy — reaching patients at fairs, shelters, and more. Get strategies to effectively engage patients in conversations about vaccines, streamline your workflow, and use community health workers to close care gaps, and hear why NCPA and CPESN are essential to the future of independent pharmacy.    Guest: Abe Funk, PharmD, owner, John's Pharmacy and John's Rx Long Term Care 

Welcome to the NeurologyLive® Mind Moments® podcast. Tune in to hear leaders in neurology sound off on topics that impact your clinical practice. In this episode, "Down Syndrome and Alzheimer's: Clinical Trials, Equity, and Patient-Centered Progress," Elizabeth Head, PhD, professor in the department of Pathology and Laboratory Medicine at the University of California, Irvine, discussed the evolving intersection of Down syndrome and Alzheimer disease using updates from the Alzheimer Biomarker Consortium – Down Syndrome (ABC-DS). She detailed how outcome assessments have been refined to meet the unique cognitive profiles of individuals with Down syndrome and shared the progress in launching clinical trials that now include this historically excluded population. Head also addressed the challenges in distinguishing developmental delay from early dementia symptoms, the potential role of anti-amyloid therapies, and how non-pharmacological interventions like sleep apnea treatment may contribute to cognitive preservation. She emphasized the importance of equitable research participation, clinician education, and understanding patient priorities—like independence and respect—when supporting individuals with Down syndrome and their families. Looking for more Alzheimer disease/dementia discussion? Check out the NeurologyLive® Alzheimer disease/dementia clinical focus page. Episode Breakdown: 1:00 – Overview of the ABC-DS initiative and the growing inclusion of Down syndrome in Alzheimer research 2:00– Current state of clinical trials and progress in therapeutic development for this population 3:30 – Evolution of outcome assessments tailored for individuals with Down syndrome 5:40 – Challenges in distinguishing Down syndrome traits from signs of early dementia 7:40 – Clinician educations needs and improving access to specialized care 9:00 – Neurology News Minute 11:00 – Eligibility and considerations for anti-amyloid therapies in Down syndrome 13:35 – Research gaps, co-occurring conditions, and the importance of reaching underserved populations 16:40 – Top priorities from patients and families: independence, inclusion, and respect in care settings The stories featured in this week's Neurology News Minute, which will give you quick updates on the following developments in neurology, are further detailed here: GENERATION HD2 Trial of Huntington Agent Tominersen Amended to Include Only Higher Dose FDA Grants Authorization to Epiminder's Implantable Continuous EEG Monitor for Epilepsy Treatment FDA Approves FcRn Blocker Nipocalimab for Broad Forms of Generalized Myasthenia Gravis Thanks for listening to the NeurologyLive® Mind Moments® podcast. To support the show, be sure to rate, review, and subscribe wherever you listen to podcasts. For more neurology news and expert-driven content, visit neurologylive.com.

In this episode of the Becker's Healthcare Podcast, Brian Zimmerman is joined by Dr. Ujjwal Ramtekkar, Chief Medical Officer at LifeStance Health, to discuss how organizations can scale behavioral health services while maintaining a strong focus on both patients and clinicians. Dr. Ramtekkar shares insights into building a high-performing clinical workforce, elevating quality across a large national team, and creating feedback-driven systems that prioritize frontline perspectives. Tune in to learn how LifeStance is navigating today's behavioral health challenges through intentional, clinician-first strategies.This episode is sponsored by LifeStance.

Mikkael A. Sekeres, MD, MS, University of Miami Sylvester Comprehensive Cancer Center, Miami, FL Recorded on April 17, 2025 Mikkael A. Sekeres, MD, MS Chief, Division of Hematology Professor of Medicine Sylvester Comprehensive Cancer Center University of Miami Miami, FL Join us with Dr. Mikkael Sekeres of the University of Miami Sylvester Comprehensive Cancer Center as he explores the complexities of diagnosing and treating Myelodysplastic Syndromes (MDS), including “watch and wait.” Through case-based discussion, he highlights advances in high-risk MDS management, from novel targeted therapies to stem cell transplantation and clinical trials. Dr. Sekeres also shares strategies for managing side effects and emphasizes the importance of multidisciplinary care in improving patient outcomes. Tune in to gain valuable insights on MDS today!

Between Mayo Clinic, the University of Minnesota Medical School, and companies like 3M, it's no secret that Minnesota is a hub for medical startups and innovation. But it often takes years for new treatments and practices to hit the mainstream. Two Minnesotans in the health care industry started a podcast called “Patient Innovations” to inform patients and medical providers about the cutting-edge medicine coming out of the state. Co-hosts Rashmi Kandwal and Mary MacCarthy joined Minnesota Now to talk about the podcast.

Despite the substantial impact hidradenitis suppurativa can have on patients, many don't have a diagnosis or seek treatment. With better understanding of the disease and new and emerging treatment options, now is a great time to focus on identifying the disease and providing care, says Wendy Cantrell, DNP, CRNP. Also in this episode, Jenny Murase, MD, FAAD offers tips for getting to the root of itch, and Joe Gorelick, MSN, FNP-C addresses rosacea awareness.Like what you're hearing? Want to learn more about the Dermatology Education Foundation? Explore assets and resources on our website.

Lindsay Dymowski is transforming pharmacy with innovative medication management, value-based care, and patient-focused solutions Lindsay Dymowski, co-founder and president of Centennial Pharmacy Services, is rethinking how independent pharmacies support patient care, chronic disease management, and value-based healthcare. In this episode, she discusses medication adherence, Medicare changes, and why pharmacies should do more than just dispense pills; they should improve patient outcomes. Tune in to learn how innovative pharmacy services are transforming patient care, improving medication management, and shaping the future of value-based healthcare! Resources: Connect with and follow Lindsay Dymowski on LinkedIn. Follow Centennial Pharmacy Services on LinkedIn and visit their website! Explore the LTC@Home Pharmacy Network website!

In this bonus episode co-produced with Vital, we're talking patient satisfaction: how to create a meaningful connection in a short amount of time, and why it matters. (Spoiler alert: It's not all about metrics.) Join EMRA*Cast alumni Masood Mohammed and guest Gus Garmel for this practice-elevating conversation.

In this episode of the "My DPC Story" podcast, host Dr. Maryal Concepcion chats with Dr. Manvinder Kainth about her journey in Direct Primary Care (DPC). Dr. Kainth, a board-certified family medicine physician, discusses how her experiences with healthcare systems in Canada and the U.S. shaped her practice philosophy. She shares insights from her residency, which taught her the intricacies of the insurance-driven system, and how it propelled her towards DPC as a more personal and efficient model. Dr. Kainth emphasizes the flexibility and simplicity of DPC, highlighting her commitment to offering personalized and affordable care at her clinic, Maple Primary Care, in Plano, Texas. Throughout the episode, she provides valuable advice for new DPC physicians on setting boundaries, maintaining patient relationships, and navigating the business side of medicine. This episode is a must-listen for medical professionals contemplating a shift from the traditional healthcare model to a more patient-centric approach. Listen in to gain inspiration and practical tips on thriving in the DPC space.FREE MARKET MEDICAL ASSOCIATION (FMMA) 4/9-11/25: Use code MYDPCSTORY for $800 off your FMMA Annual Conference registration! -> SPRUCE HEALTH: NEW USERS get 20% off your SPRUCE HEALTH paid plan with code: MARYAL20Support the showBe A My DPC Story PATREON MEMBER! SPONSOR THE PODMy DPC Story VOICEMAIL! DPC SWAG!FACEBOOK * INSTAGRAM * LinkedIn * TWITTER * TIKTOK * YouTube

Building a thriving optometry practice isn't about luck — It's about strategy, efficiency, and data-driven decisions. Dr. David Cockrell has spent over 40 years refining the formula for success, turning his practice into a 12,000 sq. ft. powerhouse where five doctors each see 40 patients a day, without sacrificing quality of care.